DACLATASVIR
Dacarbazine hydrochloride is an alkylating agent used in melanoma and Hodgkin lymphoma. Side effects include nausea, myelosuppression, and liver toxicity. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Daclatasvir is a directacting antiviral that targets the hepatitis C virus (HCV) nonstructural protein NS5A. It binds domain I of NS5A, disrupting viral RNA replication complex formation and virion assembly. It is active across multiple HCV genotypes when combined with other DAAs.
Benefits and Advantages
Used in HCVreplication research, NS5Astructure/function studies, antiviral combinationtherapy modelling, resistancemutation analysis and hostvirus interaction assays.
Side Effects and Risks
Risks include headache, fatigue, bradyarrhythmias (with amiodarone), hepatic enzyme elevations and drugdrug interactions via CYP3A. Handle as a potent antiviral compound.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C40H50N8O6 |
|---|---|
| Molecular Weight | 738.9 g/mol |
| CAS Number | 1009119-64-5 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Freely soluble (>700 mg/mL) |
| Purity | Purity information is available upon request (COA). |
| Synonym | Daclatasvir; 1009119-64-5; BMS-790052; BMS790052; BMS 790052 |
| IUPAC/Chemical Name | methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
| InChl Key | FKRSSPOQAMALKA-CUPIEXAXSA-N |
| InChl Code | InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
